COMMON STOCK PURCHASE WARRANT JANONE INC.JanOne Inc. • May 6th, 2024 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 1, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from JanOne Inc., a Nevada corporation (the “Company”), up to _____ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 6th, 2024 • JanOne Inc. • Pharmaceutical preparations • Nevada
This Securities Purchase Agreement (this “Agreement”) is dated as of May 1, 2024, between JanOne Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
May 1, 2024JanOne Inc. • May 6th, 2024 • Pharmaceutical preparations
We are rendering this letter as outside securities counsel to the Issuer in connection with the sale and issuance by the Issuer of 79,892 units (the “Units”) of its securities, each Unit consisting of: one share of the Issuer’s common stock, par value $0.001 per share (“Common Stock”), and one common stock purchase warrant for the purchase of an additional share of Common Stock (“Warrants”). Each Warrant will be exercisable immediately following issuance. The shares of Common Stock and the Warrants were sold pursuant to the Securities Purchase Agreement, dated May 1, 2024 (the “SPA”), by and among the Issuer and the Purchasers.
